Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin-Reference-Cited by-同舟云学术

Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin

Published:2018-08-20 Issue:1 Volume:54 Page:73-80
ISSN:1383-875X
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Avendano Ricardo^ORCID,Romero Jorge,Lupercio Florentino,Diaz Juan Carlos,Quispe Renato,Golive Anjani,Natale Andrea,Garcia Mario J.,Krumerman Andrew K.,Di Biase Luigi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s10840-018-0427-y/fulltext.html

Reference21 articles.

1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119–25. https://doi.org/10.1161/CIRCULATIONAHA.105.595140 .

2. Di Minno A, Spadarella G, Tufano A, Prisco D, Di Minno G. Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). Thromb Res. 2014;133(5):699–704. https://doi.org/10.1016/j.thromres.2014.01.016 .

3. Contreras Muruaga MDM, Vivancos J, Reig G, Gonzalez A, Cardona P, Ramirez-Moreno JM, et al. Satisfaction, quality of life and perception of patients regarding burdens and benefits of vitamin K antagonists compared with direct oral anticoagulants in patients with nonvalvular atrial fibrillation. J Comp Eff Res. 2017;6(4):303–12. https://doi.org/10.2217/cer-2016-0078 .

4. Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E, et al. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart. 2017;103(4):307–14. https://doi.org/10.1136/heartjnl-2016-309832 .

5. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51. https://doi.org/10.1056/NEJMoa0905561 .

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does amiodarone impact on apixaban levels? The effect of amiodarone on apixaban level among Thai patients with non-valvular Atrial Fibrillation;PLOS ONE;2024-01-19

2. Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older Adults;CJC Open;2021-11

3. Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis;Cardiovascular Drugs and Therapy;2021-10-12

4. Multimorbidity, physical frailty, and self-rated health in older patients with atrial fibrillation;BMC Geriatrics;2020-09-11